e.l.f. Beauty, Inc.

NYSE:ELF Stock Report

Market Cap: US$6.8b

e.l.f. Beauty Valuation

Is ELF undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of ELF when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: ELF ($121.33) is trading below our estimate of fair value ($322.23)

Significantly Below Fair Value: ELF is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for ELF?

Key metric: As ELF is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for ELF. This is calculated by dividing ELF's market cap by their current earnings.
What is ELF's PE Ratio?
PE Ratio63.3x
EarningsUS$107.99m
Market CapUS$6.83b

Price to Earnings Ratio vs Peers

How does ELF's PE Ratio compare to its peers?

The above table shows the PE ratio for ELF vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average32.7x
COTY Coty
39.8x23.3%US$6.3b
BRBR BellRing Brands
42.2x12.3%US$9.3b
IPAR Interparfums
26.5x7.9%US$4.0b
ODD Oddity Tech
22.4x18.5%US$2.3b
ELF e.l.f. Beauty
63.3x33.6%US$6.8b

Price-To-Earnings vs Peers: ELF is expensive based on its Price-To-Earnings Ratio (63.3x) compared to the peer average (32.7x).

Price to Earnings Ratio vs Industry

How does ELF's PE Ratio compare vs other companies in the US Personal Products Industry?

1 CompanyPrice / EarningsEstimated GrowthMarket Cap
NEPT.F Neptune Wellness Solutions
n/an/aUS$4.00
No more companies available in this PE range
ELF 63.3xIndustry Avg. 26.5xNo. of Companies4PE01632486480+
1 CompanyEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: ELF is expensive based on its Price-To-Earnings Ratio (63.3x) compared to the North American Personal Products industry average (26.5x).

Price to Earnings Ratio vs Fair Ratio

What is ELF's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

ELF PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio63.3x
Fair PE Ratio39.9x

Price-To-Earnings vs Fair Ratio: ELF is expensive based on its Price-To-Earnings Ratio (63.3x) compared to the estimated Fair Price-To-Earnings Ratio (39.9x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst ELF forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentUS$121.33
US$158.50
+30.6%
13.1%US$200.00US$115.00n/a14
Nov ’25US$103.12
US$169.07
+64.0%
18.9%US$250.00US$130.00n/a14
Oct ’25US$105.97
US$199.43
+88.2%
17.6%US$250.00US$139.00n/a14
Sep ’25US$149.79
US$221.92
+48.2%
11.6%US$260.00US$161.00n/a13
Aug ’25US$167.62
US$223.62
+33.4%
11.5%US$258.00US$161.00n/a13
Jul ’25US$204.16
US$209.92
+2.8%
11.9%US$250.00US$151.00n/a13
Jun ’25US$186.91
US$202.62
+8.4%
9.7%US$220.00US$151.00n/a13
May ’25US$158.52
US$206.21
+30.1%
8.2%US$230.00US$167.00n/a14
Apr ’25US$191.97
US$208.21
+8.5%
7.9%US$230.00US$167.00n/a14
Mar ’25US$217.40
US$203.08
-6.6%
8.0%US$225.00US$167.00n/a13
Feb ’25US$162.50
US$171.58
+5.6%
9.1%US$190.00US$141.00n/a12
Jan ’25US$144.34
US$143.33
-0.7%
12.4%US$178.00US$119.00n/a12
Dec ’24US$122.44
US$139.92
+14.3%
11.0%US$178.00US$119.00n/a12
Nov ’24US$94.54
US$143.25
+51.5%
9.7%US$176.00US$117.00US$103.1212
Oct ’24US$109.83
US$147.25
+34.1%
11.4%US$176.00US$110.00US$105.9712
Sep ’24US$136.97
US$146.91
+7.3%
11.4%US$165.00US$110.00US$149.7911
Aug ’24US$116.50
US$121.09
+3.9%
15.2%US$164.00US$90.00US$167.6211
Jul ’24US$114.23
US$111.82
-2.1%
12.4%US$130.00US$87.00US$204.1611
Jun ’24US$106.54
US$106.82
+0.3%
9.5%US$121.00US$87.00US$186.9111
May ’24US$92.72
US$96.18
+3.7%
13.4%US$114.00US$70.00US$158.5211
Apr ’24US$82.35
US$76.27
-7.4%
15.2%US$94.00US$57.00US$191.9711
Mar ’24US$74.19
US$72.09
-2.8%
10.2%US$82.00US$57.00US$217.4011
Feb ’24US$58.51
US$57.50
-1.7%
15.9%US$65.00US$36.00US$162.5010
Jan ’24US$55.30
US$53.40
-3.4%
16.7%US$65.00US$36.00US$144.3410
Dec ’23US$55.40
US$49.80
-10.1%
13.5%US$63.00US$36.00US$122.4410
Nov ’23US$43.70
US$44.60
+2.1%
8.0%US$50.00US$36.00US$94.5410

Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.

Discover undervalued companies

Ascend Wellness Holdings

US$106.1m

Engages in the cultivation, manufacture, and distribution of cannabis consumer packaged goods in the United States.

AAWH

US$0.47

7D

-22.5%

1Y

-59.2%

Kimberly-Clark

US$44.7b

Manufactures and markets personal care and consumer tissue products in the United States.

KMB

US$134.08

7D

0.4%

1Y

10.6%

Beauty Health

US$222.2m

Designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide.

SKIN

US$1.53

7D

-6.1%

1Y

-32.3%